# Ernexa Therapeutics Inc.: Form 8-K, filed Jan 15, 2021

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2021-01-15
- Accepted by EDGAR: Jan 15, 2021, 17:22 ET
- Period: 2021-01-12
- Accession: 0001493152-21-001197
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315221001197/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315221001197/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315221001197/form8-k.htm

Filed Jan 15, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-001197. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
